Latest news

CONMED Corp (NYSE:CNMD) is withdrawing its FY22 financial outlook, citing a temporary disruption resulting from implementing new warehouse management software.…

Needham analyst Mike Matson maintains Conmed (NYSE:CNMD) with a Buy and raises the price target from $90 to $106.

Needham analyst Mike Matson maintains Conmed (NYSE:CNMD) with a Buy and lowers the price target from $123 to $90.

  During Wednesday's trading, 517 companies set new 52-week lows.

Upgrades

  On Tuesday, 838 companies hit new 52-week lows.

  During Monday's trading, 528 companies set new 52-week lows.

  On Tuesday, 456 stocks hit new 52-week lows.

  On Thursday, 1076 companies hit new 52-week lows.

  On Thursday, 529 companies set new 52-week lows.